New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
13:13 EDTMRVL, QCOR, LRCX, MU, MNK, AAPL, RADEinhorn bought Lam Research shares, sold Rite Aid last quarter
Well-known investor David Einhorn said his hedge fund, Greenlight Capital, had taken a new long position last quarter in Lam Research (LRCX), which develops equipment for semiconductor companies. Also last quarter, Greenlight sold out of its position in Rite Aid (RAD), Einhorn revealed. WHAT'S NEW: Greenlight made a "medium-sized" new investment in Lam Research, Einhorn revealed in his quarterly letter to investors. As the size of transistors shrink, chip makers must run each layer of chips through the manufacturing line multiple times until they work properly, the investor stated. Consequently, the chip makers must buy more of Lam's tools for each manufacturing line, Einhorn explained. The valuations of many high momentum stocks in the tech sector are excessive, but not all tech stocks are too expensive, Einhorn contended. A number of tech stocks - including Apple (AAPL), Lam Research, Marvell Technology (MRVL) and Micron Technology (MU) - "have strong prospects and are undervalued," Einhorn declared. Greenlight holds long positions in all those stocks. Greenlight sold its position in Rite Aid because the company's sales and profits rose, as the hedge fund had expected, and the stock reached fair value, Einhorn explained. WHAT'S NOTABLE: Greenlight continues to be short Questcor (QCOR), which has "a laundry list of problems and risks," the investor said. Among these are ongoing criminal probes and a large number of adverse events, including deaths, experienced by a number of patients who were taking the company's only drug, Acthar, Einhorn wrote. Additionally, a number of insurers have moved towards limiting their reimbursement of the drug, he added. The FDA is examining lab reports which suggest that Questcor's product does not include a highly purified form of Acthar as promoted by the company but a degraded form of the drug, the investor alleged. Mallinckrodt Pharmaceuticals (MNK), which has agreed to buy Questcor, is not properly evaluating the risks of Questcor's drug, Einhorn stated. Mallinckrodt "is setting itself up to be a very attractive short sale candidate if the merger is completed," Einhorn believes. PRICE ACTION: In early afternoon trading, Lam Research lost 1.5% to $69, Rite Aid slid 3.5% to $7, Questcor lost 2% to $95, and Mallinckrodt dropped 3% to $74.50.
News For LRCX;RAD;MNK;QCOR;AAPL;MU;MRVL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
November 18, 2015
10:47 EDTAAPLTarget sees Apple Watch to be top gift in wearable category in holiday season
Subscribe for More Information
10:00 EDTAAPLOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Apple (AAPL) upgraded to Conviction Buy from Buy at Goldman... BorgWarner (BWA) upgraded to Buy from Neutral at Goldman... Cognex (CGNX) upgraded to Buy from Hold at Canaccord... FARO Technologies (FARO) upgraded to Buy from Hold at Canaccord... Lazard (LAZ) upgraded to Strong Buy from Outperform at Raymond James... LendingClub (LC) upgraded on valuation, positive outlook at Sterne Agee CRT... Middleby (MIDD) upgraded to Outperform from Market Perform at BMO Capital... Perrigo (PRGO) upgraded to Buy from Neutral at B. Riley... RE/MAX Holdings (RMAX) upgraded to Market Perform from Underperform at JMP Securities... Sally Beauty (SBH) upgraded to Buy from Neutral at Goldman... Shopify (SHOP) upgraded to Outperform from Market Perform at Raymond James... TASER (TASR) upgraded to Buy from Neutral at Ladenburg... USG (USG) upgraded to Buy from Neutral at Northcoast.
09:52 EDTAAPLApple trades up, Goldman adds to Conviction Buy List
The stock was last at $116.89, up over 2.8% on the session on moderate volume. At current price next resistance is at $119.27. Support is at $115.75, the opening price of the day.
09:34 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:19 EDTLRCXRBC Capital to hold a tour
Subscribe for More Information
06:14 EDTAAPLApple upgraded to Conviction Buy from Buy at Goldman
Goldman Sachs analyst Simona Jankowski upgraded Apple to Conviction Buy saying the stock trades at a 30% discount to the S&P 500 multiple. The market views Apple as a "hardware" stock, or a company with limited recurring revenue and visibility that only extends to the next product cycle, Jankowski tells investors in a research note. Over the next year, however, the analyst expects the market focus will shift from unit growth to installed base monetization and recurring revenues, which she dubs "Apple-as-a-Service." Jankowski believes Apple has a "significant multi-year opportunity" to increase monetization given its estimated installed base of 500M loyal iPhone users. She has a $163 price target for shares. The iPhone maker closed yesterday down 49c to $113.69.
06:12 EDTAAPLApple Pay coming to Domino's by end of year, Cinnabon in 2016, AP reports
Apple (AAPL) yesterday said that company-owned Domino's (DPZ) pizza outlets will be accepting Apple Pay by the end of 2015, while Cinnabon plans to integrate the mobile payments solution in its stores in 2016, The Associated Press reports. Reference Link
05:56 EDTAAPLSony Mobile, LG to develop smartphone app processors in-house, DigiTimes says
Subscribe for More Information
05:51 EDTMNKMallinckrodt price increase raises new questions, WSJ says
Subscribe for More Information
05:40 EDTRADStocks with implied volatility below IV index mean; YUM RAD
Subscribe for More Information
05:39 EDTMNKMallinckrodt raised infant seizure drug price by 2,000%, CBC reported
Subscribe for More Information
November 17, 2015
16:01 EDTAAPLOptions Update; November 17, 2015
iPath S&P 500 VIX Short-Term Futures up 1.32 to 21.07. Option volume leaders: GE BAC AAPL FB NFLX SYF WMT CSCO MU SUNE VRX BABA AMZN HD FCX
11:10 EDTMUMicron the most likely target for Tsinghua stake, says Macquarie
Macquarie analyst Deepon Nag highlighted yesterday that Tsinghua Unigroup Chairman Zhao Weiguo told Reuters in an interview that his company was in talks with a U.S. semiconductor company, and that a deal could be announced as early as the end of the month. Zhao stated that a majority stake was unlikely due to regulatory concerns. Given recent moves by China in the memory market, Micron (MU) is the most likely target for Tsinghua, Nag wrote in a note to investors. Tsinghua recently announced a 15% stake in Western Digital (WDC) at a 33% premium to the company's prior closing price. A similar premium for Micron would lead to a 15% stake in Micron for $20 per share, which would equal $3.4B, the analyst points out. Shares of Micron are up 46c, or 3%, to $15.35 in late morning trading. Nag has an Outperform rating on Micron with a $30 price target.
11:03 EDTMUTsinghua Chairman says in talks with U.S.-based chipmaker, Reuters reports
Subscribe for More Information
11:02 EDTMUMicron calls active on speculation of a Chinese investment
Micron November 15.5 and 16 calls are active on total call volume of 27K contracts (12K puts) on speculation of a Chinese investment. November call option implied volatility is at 65, December is at 55; compared to its 52-week range of 28 to 74. Active call volume suggests traders taking positions for upside price movement.
09:35 EDTAAPLActive equity options trading on open: AAPL FB GE HD
Subscribe for More Information
09:02 EDTAAPLAnalyst pans competing products, says buy Fitbit
Shares of previous high-flier Fitbit (FIT) have dropped about 30% in the last two weeks following the company's third quarter earnings report, but an analyst at Bank of America upgraded his view of the fitness tracker maker this morning, saying that now is the time to buy ahead of fourth quarter results that may be boosted by the "underwhelming" new products being launched by its competitors. UNDERWHELMING COMPETITION: Fitbit's sales guidance for this holiday quarter looks conservative, contends Bank of America analyst Nat Schindler, who notes that the company only had the launch of one new product last December but will have the Charge, Charge HR and Surge to drive sales this season. Schindler also notes that the company's international advertising has expanded into more countries ahead of the holidays this year. Key, however, may be the "underwhelming" lineup of new or updated fitness trackers launched by competitors, such as the Microsoft's (MSFT) Band 2, Jawbone's UP4 and Sony's (SNE) Smartband 2, many of which have only minor improvements and no "must have" features to pull consumers away from Fitbit, Schindler told investors in his research note. PLATFORM PICKING UP STEAM: The analyst also pointed out that Fitbit now has more than 20 companies signed onto its health and wellness platform, including big names like Target (TGT) and Barclays (BCS), which he believes should help drive revenue beats in the upcoming fiscal year due to increased device sales. Also, the additional dashboard data should help Fitbit maintain long-term user engagement, said Schindler. APPLE WATCH: Apple's (AAPL) Apple Watch is largely viewed as the biggest potential competitive threat to Fitbit's offerings, but on the fitness tracker maker's last earnings call CEO James Park said Fitbit's products differ from those of its competitors in several key aspects, including pricing, cross-platform compatibility, brand awareness and product line breadth. Other wearables makers include Garmin (GRMN) and Samsung. PRICE ACTION: Since the day after Fitbit's last earnings report after the market close on November 2, its shares have fallen about 29.5% to close yesterday at $28.80. In pre-market trading this morning, Fitbit shares rose 2% to $29.40.
08:35 EDTMRVLMarvell submitted compliance plan to NASDAQ
Subscribe for More Information
07:56 EDTMUUBS to hold a conference
Global Technology Conference is being held in San Francisco on November 16-18 with webcasted company presentations to begin on November 17 at 10:45 am.; not all company presentations may be webcasted. Webcast Link
07:01 EDTAAPLGlobal Payments to offer Apple Pay support in Canada
Global Payments (GPN) said it will offer its merchants in Canada the ability to accept American Express (AXP) payments made with Apple (AAPL) Pay. As an Apple Pay-qualified payment provider, Global Payments' robust suite of payments solutions is fully enabled for Apple Pay acceptance, allowing merchants to offer their customers the convenience of Apple Pay acceptance in-store, in-app and on-the-go.
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use